Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Ad26.COV2.S
Australian Public Assessment Report
Device/Product Name
COVID-19 Vaccine Janssen
Active ingredients
Ad26.COV2.S
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-06173-1-2
Submission Type
New biological entity
Decision
Approved for provisional registration